Legend Biotech Corporation
LEGN
$27.75
$1.063.97%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 6.77% | 30.82% | |||
| Total Other Revenue | 500.00% | -96.67% | |||
| Total Revenue | 6.77% | 30.76% | |||
| Cost of Revenue | 16.38% | 13.29% | |||
| Gross Profit | -25.34% | 169.75% | |||
| SG&A Expenses | 8.29% | 11.34% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 14.03% | 12.71% | |||
| Operating Income | -98.58% | 56.80% | |||
| Income Before Tax | 68.69% | -25.89% | |||
| Income Tax Expenses | 5.84% | -67.41% | |||
| Earnings from Continuing Operations | 68.35% | -24.24% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 68.35% | -24.24% | |||
| EBIT | -98.58% | 56.80% | |||
| EBITDA | -113.02% | 59.58% | |||
| EPS Basic | 68.42% | -23.98% | |||
| Normalized Basic EPS | 68.77% | -26.86% | |||
| EPS Diluted | 67.69% | -23.98% | |||
| Normalized Diluted EPS | 68.77% | -26.86% | |||
| Average Basic Shares Outstanding | 0.27% | 0.20% | |||
| Average Diluted Shares Outstanding | 0.27% | 0.20% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||